We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$15.1B
AUM Growth
+$2.22B
Cap. Flow
+$548M
Cap. Flow %
3.64%
Top 10 Hldgs %
28.62%
Holding
2,384
New
671
Increased
477
Reduced
577
Closed
562

Sector Composition

Rank Sector Weight
1 Industrials 11.79%
2 Technology 9.94%
3 Financials 9.21%
4 Consumer Discretionary 9.11%
5 Healthcare 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CW icon
1126
Curtiss-Wright
CW
$22.7B
$775K 0.01%
3,480
-237
-6% -$49.6K
RDN icon
1127
Radian Group
RDN
$4.86B
$774K 0.01%
+27,125
New +$715K
TNC icon
1128
Tennant Co
TNC
$1.16B
$771K 0.01%
+8,320
New +$690K
RLJ icon
1129
RLJ Lodging Trust
RLJ
$1.76B
$771K 0.01%
+65,800
New +$684K
PTLO icon
1130
Portillo's
PTLO
$361M
$771K 0.01%
+48,400
New +$748K
DOO
1131
Bombardier Recreational Products
DOO
$4.68B
$767K 0.01%
+10,700
New +$748K
UNFI icon
1132
United Natural Foods
UNFI
$2.94B
$766K 0.01%
47,202
-114,677
-71% -$1.74M
LOPE icon
1133
Grand Canyon Education
LOPE
$3.85B
$762K 0.01%
+5,770
New +$751K
INVA icon
1134
Innoviva
INVA
$1.52B
$761K 0.01%
+47,418
New +$663K
AKYA
1135
DELISTED
Akoya BioSciences
AKYA
$760K 0.01%
155,800
+26,300
+20% +$109K
COUR icon
1136
Coursera
COUR
$1.59B
$755K 0.01%
+39,000
New +$745K
DOCS icon
1137
Doximity
DOCS
$4.51B
$754K 0.01%
+26,900
New +$635K
SLGC
1138
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$751K 0.01%
+297,000
New +$692K
SWX icon
1139
Southwest Gas
SWX
$6.49B
$751K 0.01%
+11,855
New +$713K
NAMS icon
1140
NewAmsterdam Pharma
NAMS
$3.21B
$747K 0.01%
66,900
+2,200
+3% +$20.2K
BAH icon
1141
Booz Allen Hamilton
BAH
$9.05B
$744K ﹤0.01%
+5,815
New +$725K
SLRC icon
1142
SLR Investment Corp
SLRC
$693M
$742K ﹤0.01%
+49,400
New +$737K
MEDP icon
1143
Medpace
MEDP
$17.3B
$741K ﹤0.01%
2,418
+784
+48% +$212K
PSMT icon
1144
Pricesmart
PSMT
$5.4B
$741K ﹤0.01%
+9,780
New +$694K
GLW icon
1145
Corning
GLW
$125B
$740K ﹤0.01%
+24,298
New +$695K
AKAM icon
1146
Akamai
AKAM
$15.2B
$739K ﹤0.01%
+6,242
New +$694K
HTLD icon
1147
Heartland Express
HTLD
$967M
$735K ﹤0.01%
+51,576
New +$705K
VRP icon
1148
Invesco Variable Rate Preferred ETF
VRP
$3.02B
$734K ﹤0.01%
+31,823
New +$712K
MGNX icon
1149
MacroGenics
MGNX
$256M
$733K ﹤0.01%
+76,246
New +$527K
OUT icon
1150
Outfront Media
OUT
$5.36B
$733K ﹤0.01%
+53,339
New +$603K

Similar funds

Steve Schonfeld's Q4 2023 Portfolio in Review

As of Q4 2023, Steve Schonfeld held 2,384 positions worth $15.1B, up 17% from $12.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Steve Schonfeld deployed $548M of net new capital in Q4 2023, opening 671 new positions and adding to 477 existing holdings. Its largest new stake was Equifax: 214,316 shares worth $53M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Union Pacific, an estimated $115M trimmed.

  • Steve Schonfeld's largest Q4 2023 buy was Equifax: 214,316 shares worth $53M.
  • Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.67B increase.
  • Steve Schonfeld's biggest Q4 2023 reduction was Union Pacific, cutting an estimated $115M.
  • Steve Schonfeld fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2023, selling an estimated $94.5M.
  • Steve Schonfeld's ten largest holdings make up 29% of its $15.1B portfolio in Q4 2023.
  • Steve Schonfeld opened 671 new positions and closed 562 in Q4 2023.
  • Steve Schonfeld's portfolio value rose 17% quarter-over-quarter to $15.1B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.